Pathology of lung cancer.
This article reviews current concepts in pathologic classification of lung cancer based on 1999 World Health Organization (WHO)/International Association for the Study of Lung Cancer (IASLC) classification. Preinvasive lesions including squamous dysplasia/carcinoma in situ, atypical adenomatous hyperplasia and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia are discussed in addition to current concepts of bronchioloalveolar carcinoma and neuroendocrine tumors.
Travis
William D
WD
Department of Pulmonary and Mediastinal Pathology, Armed Forces Institute of Pathology, Washington, D.C., USA.
D000230:Adenocarcinoma / Q000145:classification / Q000473:pathology; D002276:Carcinoid Tumor / Q000145:classification / Q000473:pathology; D018287:Carcinoma, Large Cell / Q000145:classification / Q000473:pathology; D018288:Carcinoma, Small Cell / Q000145:classification / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000145:classification / Q000473:pathology; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000145:classification / Q000473:pathology*; D008297:Male; D011230:Precancerous Conditions / Q000473:pathology*; D011379:Prognosis; D012509:Sarcoma / Q000145:classification / Q000473:pathology